NewGen Provides Recap of Strategic Progress as Diversification Fuels Success, Positions Company for Breakout Year

Core Insights - NewGenIVF Group has undergone a significant financial and operational transformation, achieving US$28 million in net assets and positioning itself for substantial value creation in 2026 and beyond [1][2][6] Financial Position - The company has improved its financial standing by turning a historical deficit into a robust US$28 million in net assets as of September 30, 2025, through proactive capital management and strategic asset deployment [2][6] - A $2 million share repurchase program was authorized in November 2025, reflecting management's confidence in the company's intrinsic value and commitment to returning value to shareholders [6][7] Strategic Initiatives - NewGen has strategically invested in a diversified portfolio, including the acquisition of advanced cytometry intellectual property valued at US$17.9 million, which will serve as the foundation for a new technology-licensing business [3][4] - The company is exploring opportunities in real estate development in Ras Al Khaimah, UAE, and has initiated digital asset innovation through its NewGenDigital division, focusing on Real World Asset (RWA) tokenization and art tokenization services [4][9] Growth Prospects - NewGen has launched a Commitment Campaign for its inaugural tokenized bond issuance on Evident Capital's platform, aiming to transform its balance sheet and unlock new capital sources for business development [5][6] - The company is entering 2026 with a clear growth strategy and tangible assets, indicating a transition from a foundational phase to a harvesting phase, ready to unlock significant value for shareholders [7][8]